Before start of treatment patients will receive a 3T MRI (T1 SE and T2 TSE), an MRS determining the choline creatine levels in the prostate. Furthermore, an MV-CT will be made as a prelude to future position verification studies. All images (CT, MRI and MRS) will be matched. These combined data will be used to determine an optimal Tomotherapy IMRT plan.